-
Cloud-Clone MSR1 kit plays a key role in the study of rheumatoid arthritis diagnostic markers
On April 20,2020,professor Zhanguo Li and profressor Xiang-Yang Wang from department of Human & Molecular Genetics, Virginia Commonwealth University co-authored with professor Liang Liu from Macau University of Science and Technology, published a paper titled Scavenger receptor-A is a biomarker and effector of rheumatoid arthritis: A large-scale multicenter study on Nature commnications.The ELISA kit (MSR1, SEB591Hu) of Cloud-Clone brand was chosed to determine the concentation of MSR1 in this article, we are so proud for supporting the reaserchers. The paper reports a large-scale multicenter study involving training and validation cohorts of 3,262 participants. It shows that serum lev......
-
Cloud-Clone's SMD ELISA Kit has a good performance!
On February 18, 2020,professor Kodi S.Ravichandran from Center for Cell Clearance of University of Virginia co-authored with professor Ulrike Lorenz from Biomedical Molecular Biology of Ghent university published a paper named “Metabolites released from apoptotic cellsact as tissue messengers” on Nature.The ELISA kit (SMD, CEX053Ge) of Cloud-Clone brand was chosed to determine the concentation of SMD in this article, we are so proud for supporting the reaserchers. The paper profiled the apoptotic metabolite secretome and determined its effects on the tissue neighbourhood. It shows that apoptotic lymphocytes and macrophages release specific metabolites, while retaining their membr......
-
Literature of Cloud Clone products in Aug. 2020 (Excerpt)
In Aug. 2020, Literature of Cloud Clone products has exceeded 260. Cloud-Clone could provide multipleproteins, antibodies and ELISA kit, which has been praised by customers.(For more information, please visit: www.cloud-clone.com/www.uscnk.cn)
-
Cloud-Clone Is Coming!
CLOUD-CLONE CORP. (CCC, USA), a research and experimental development in molecular biology and immunology oriented company headquartered in Houston, is the owner of the trade mark “Cloud-Clone”. Its main business includesproduction of assay reagent, manufacture of analysis equipment and service for animal experiment.
-
Congratulations to professor Minjia Tan and professor Kenta Maruyama for publishing their paper on Cell.
On July 9, 2020, professor Minjia Tan from State Key Laboratory of Shanghai Institute of Materia Medica published a paper titled Integrative Proteomic Characterization of Human Lung Adenocarcinoma on Cell.Genomic studies of lung adenocarcinoma (LUAD) have advanced our understanding of the disease’s biology and accelerated targeted therapy. However, the proteomic characteristics of LUAD remain poorly understood. We carried out a comprehensive proteomics analysis of 103 cases of LUAD in Chinese patients. Integrative analysis of proteome, phosphoproteome, transcriptome, and whole-exome sequencing data revealed cancer-associated characteristics, such as tumor-associated protein variants,......
-
Literature of Cloud Clone products in JUL. 2020 (Excerpt)
In JUL. 2020, Literature of Cloud Clone products has exceeded 240. Cloud-Clone could provide multipleproteins, antibodies and ELISA kit, which has been praised by customers.(For more information, please visit: www.cloud-clone.com/www.uscnk.cn)